Skip to main content
Top
Published in: Journal of Translational Medicine 1/2013

Open Access 01-12-2013 | Research

Increased resistin in brain dead organ donors is associated with delayed graft function after kidney transplantation

Authors: Simona Oltean, Rille Pullerits, Anne Flodén, Michael Olausson, Mihai Oltean

Published in: Journal of Translational Medicine | Issue 1/2013

Login to get access

Abstract

Introduction

Resistin increases during several inflammatory diseases and after intracerebral bleeding or head trauma. Resistin activates the endothelium and may initiate an inflammatory response. No data are available on resistin in brain dead donors (DBD) that regularly manifest a pronounced inflammatory state.

Methods

We analyzed plasma resistin in 63 DBDs and correlated results with donor variables and the postoperative course following kidney transplantation using organs from these donors. Endocan and monocyte chemotactic protein (MCP)-1 were also studied. Twenty-six live kidney donors (LD) and the corresponding kidney transplantations were used as controls.

Results

DBDs had higher resistin (median/range 30.75 ng/ml, 5.41–173.6) than LD (7.71 ng/ml, 2.41–15.74, p < 0.0001). Resistin in DBD correlated with delayed graft function (DGF) in the kidney recipients (r = 0.321, p < 0.01); receiver operating characteristic curve revealed an area under the curve of 0.765 (95% confidence interval [CI] 0.648–0.881, p < 0.01) and a cut-off value for resistin of 25 ng/ml; MCP-1 and endocan were higher in DBDs (p < 0.0001) but did not correlate with DGF or acute rejection. No relationship was found between the studied molecules and the postoperative course of LD kidney transplants.

Conclusions

High resistin levels in the DBD before organ retrieval are associated with DGF after kidney transplantation. The resistin increase seems related to the inflammatory state after brain death but not to the cause of death.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koo DD, Welsh KI, McLaren AJ, Roake JA, Morris PJ, Fuggle SV: Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int. 1999, 56: 1551-1559. 10.1046/j.1523-1755.1999.00657.x.CrossRefPubMed Koo DD, Welsh KI, McLaren AJ, Roake JA, Morris PJ, Fuggle SV: Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int. 1999, 56: 1551-1559. 10.1046/j.1523-1755.1999.00657.x.CrossRefPubMed
2.
go back to reference Nijboer WN, Schuurs TA, van der Hoeven JA, Fekken S, Wiersema-Buist J, Leuvenink HG, Hofker S, Homan van der Heide JJ, van Son WJ, Ploeg RJ: Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation. 2004, 78: 978-986. 10.1097/01.TP.0000135565.49535.60.CrossRefPubMed Nijboer WN, Schuurs TA, van der Hoeven JA, Fekken S, Wiersema-Buist J, Leuvenink HG, Hofker S, Homan van der Heide JJ, van Son WJ, Ploeg RJ: Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation. 2004, 78: 978-986. 10.1097/01.TP.0000135565.49535.60.CrossRefPubMed
3.
go back to reference Weiss S, Kotsch K, Francuski M, Reutzel-Selke A, Mantouvalou L, Klemz R, Kuecuek O, Jonas S, Wesslau C, Ulrich F: Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant. 2007, 7: 1584-1593. 10.1111/j.1600-6143.2007.01799.x.CrossRefPubMed Weiss S, Kotsch K, Francuski M, Reutzel-Selke A, Mantouvalou L, Klemz R, Kuecuek O, Jonas S, Wesslau C, Ulrich F: Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant. 2007, 7: 1584-1593. 10.1111/j.1600-6143.2007.01799.x.CrossRefPubMed
4.
go back to reference Damman J, Seelen MA, Moers C, Daha MR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ: Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation. 2011, 92: 163-169. 10.1097/TP.0b013e318222c9a0.CrossRefPubMed Damman J, Seelen MA, Moers C, Daha MR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ: Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation. 2011, 92: 163-169. 10.1097/TP.0b013e318222c9a0.CrossRefPubMed
5.
go back to reference Terasaki PI, Cecka JM, Gjertson DW, Takemoto S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995, 333: 333-336. 10.1056/NEJM199508103330601.CrossRefPubMed Terasaki PI, Cecka JM, Gjertson DW, Takemoto S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 1995, 333: 333-336. 10.1056/NEJM199508103330601.CrossRefPubMed
6.
go back to reference Koerner A, Kratzsch J, Kiess W: Adipocytokines: leptin–the classical, resistin–the controversical, adiponectin–the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 2005, 19: 525-546. 10.1016/j.beem.2005.07.008.CrossRefPubMed Koerner A, Kratzsch J, Kiess W: Adipocytokines: leptin–the classical, resistin–the controversical, adiponectin–the promising, and more to come. Best Pract Res Clin Endocrinol Metab. 2005, 19: 525-546. 10.1016/j.beem.2005.07.008.CrossRefPubMed
7.
go back to reference Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006, 6: 772-783. 10.1038/nri1937.CrossRefPubMed Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006, 6: 772-783. 10.1038/nri1937.CrossRefPubMed
8.
go back to reference Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174: 5789-5795.CrossRefPubMed Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174: 5789-5795.CrossRefPubMed
9.
go back to reference Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, Kim SJ, Kim SY, Lee HK, Park KS: Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res. 2006, 69: 76-85. 10.1016/j.cardiores.2005.09.015.CrossRefPubMed Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, Kim SJ, Kim SY, Lee HK, Park KS: Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res. 2006, 69: 76-85. 10.1016/j.cardiores.2005.09.015.CrossRefPubMed
10.
go back to reference Gomez R, Conde J, Scotece M, Gomez-Reino JJ, Lago F, Gualillo O: What’s new in our understanding of the role of adipokines in rheumatic diseases?. Nat Rev Rheumatol. 2011, 7: 528-536. 10.1038/nrrheum.2011.107.CrossRefPubMed Gomez R, Conde J, Scotece M, Gomez-Reino JJ, Lago F, Gualillo O: What’s new in our understanding of the role of adipokines in rheumatic diseases?. Nat Rev Rheumatol. 2011, 7: 528-536. 10.1038/nrrheum.2011.107.CrossRefPubMed
11.
go back to reference Wagsater D, Mumtaz M, Lofgren S, Hugander A, Dimberg J: Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype. Cancer Invest. 2008, 26: 1008-1014. 10.1080/07357900802087267.CrossRefPubMed Wagsater D, Mumtaz M, Lofgren S, Hugander A, Dimberg J: Resistin in human colorectal cancer: increased expression independently of resistin promoter -420C > G genotype. Cancer Invest. 2008, 26: 1008-1014. 10.1080/07357900802087267.CrossRefPubMed
12.
go back to reference Filkova M, Haluzik M, Gay S, Senolt L: The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009, 133: 157-170. 10.1016/j.clim.2009.07.013.CrossRefPubMed Filkova M, Haluzik M, Gay S, Senolt L: The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009, 133: 157-170. 10.1016/j.clim.2009.07.013.CrossRefPubMed
13.
go back to reference Yagmur E, Trautwein C, Gressner AM, Tacke F: Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol. 2006, 101: 1244-1252. 10.1111/j.1572-0241.2006.00543.x.CrossRefPubMed Yagmur E, Trautwein C, Gressner AM, Tacke F: Resistin serum levels are associated with insulin resistance, disease severity, clinical complications, and prognosis in patients with chronic liver diseases. Am J Gastroenterol. 2006, 101: 1244-1252. 10.1111/j.1572-0241.2006.00543.x.CrossRefPubMed
14.
go back to reference Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenkuhn T, Parhofer KG, Goke B, Broedl UC: Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol. 2007, 19: 1070-1074. 10.1097/MEG.0b013e3282f16251.CrossRefPubMed Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenkuhn T, Parhofer KG, Goke B, Broedl UC: Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol. 2007, 19: 1070-1074. 10.1097/MEG.0b013e3282f16251.CrossRefPubMed
15.
go back to reference Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003, 309: 286-290. 10.1016/j.bbrc.2003.07.003.CrossRefPubMed Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003, 309: 286-290. 10.1016/j.bbrc.2003.07.003.CrossRefPubMed
16.
go back to reference Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ: Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005, 334: 1092-1101. 10.1016/j.bbrc.2005.06.202.CrossRefPubMed Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ: Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun. 2005, 334: 1092-1101. 10.1016/j.bbrc.2005.06.202.CrossRefPubMed
17.
go back to reference Sunden-Cullberg J, Nystrom T, Lee ML, Mullins GE, Tokics L, Andersson J, Norrby-Teglund A, Treutiger CJ: Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med. 2007, 35: 1536-1542. 10.1097/01.CCM.0000266536.14736.03.CrossRefPubMed Sunden-Cullberg J, Nystrom T, Lee ML, Mullins GE, Tokics L, Andersson J, Norrby-Teglund A, Treutiger CJ: Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med. 2007, 35: 1536-1542. 10.1097/01.CCM.0000266536.14736.03.CrossRefPubMed
18.
go back to reference Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C: Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care. 2009, 13: R95-10.1186/cc7925.PubMedCentralCrossRefPubMed Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C: Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care. 2009, 13: R95-10.1186/cc7925.PubMedCentralCrossRefPubMed
19.
go back to reference Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003, 108: 736-740. 10.1161/01.CIR.0000084503.91330.49.CrossRefPubMed Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003, 108: 736-740. 10.1161/01.CIR.0000084503.91330.49.CrossRefPubMed
20.
go back to reference Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel AB, Lassalle P: Endocan, a new endothelial marker in human sepsis. Crit Care Med. 2006, 34: 532-537. 10.1097/01.CCM.0000198525.82124.74.CrossRefPubMed Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T, Jourdain M, Pugin J, Tonnel AB, Lassalle P: Endocan, a new endothelial marker in human sepsis. Crit Care Med. 2006, 34: 532-537. 10.1097/01.CCM.0000198525.82124.74.CrossRefPubMed
21.
go back to reference Vilar E, Varagunam M, Yaqoob MM, Raftery M, Thuraisingham R: Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants. Transplantation. 2010, 89: 97-103. 10.1097/TP.0b013e3181be3dd1.CrossRefPubMed Vilar E, Varagunam M, Yaqoob MM, Raftery M, Thuraisingham R: Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants. Transplantation. 2010, 89: 97-103. 10.1097/TP.0b013e3181be3dd1.CrossRefPubMed
22.
go back to reference Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P, Han WK, Marcus RJ, Parikh CR: IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol. 2010, 21: 189-197. 10.1681/ASN.2009030264.PubMedCentralCrossRefPubMed Hall IE, Yarlagadda SG, Coca SG, Wang Z, Doshi M, Devarajan P, Han WK, Marcus RJ, Parikh CR: IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol. 2010, 21: 189-197. 10.1681/ASN.2009030264.PubMedCentralCrossRefPubMed
23.
go back to reference Zhang SM, Zuo L, Zhou Q, Gui SY, Shi R, Wu Q, Wei W, Wang Y: Expression and distribution of endocan in human tissues. Biotech Histochem. 2012, 87: 172-178. 10.3109/10520295.2011.577754.CrossRefPubMed Zhang SM, Zuo L, Zhou Q, Gui SY, Shi R, Wu Q, Wei W, Wang Y: Expression and distribution of endocan in human tissues. Biotech Histochem. 2012, 87: 172-178. 10.3109/10520295.2011.577754.CrossRefPubMed
24.
go back to reference van Dullemen LF, Bos EM, Schuurs TA, Kampinga HH, Ploeg RJ, van Goor H, Leuvenink HG: Brain death induces renal expression of heme oxygenase-1 and heat shock protein 70. J Transl Med. 2013, 11: 22-10.1186/1479-5876-11-22.PubMedCentralCrossRefPubMed van Dullemen LF, Bos EM, Schuurs TA, Kampinga HH, Ploeg RJ, van Goor H, Leuvenink HG: Brain death induces renal expression of heme oxygenase-1 and heat shock protein 70. J Transl Med. 2013, 11: 22-10.1186/1479-5876-11-22.PubMedCentralCrossRefPubMed
25.
go back to reference Schwarz C, Regele H, Steininger R, Hansmann C, Mayer G, Oberbauer R: The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation. 2001, 71: 1666-1670. 10.1097/00007890-200106150-00028.CrossRefPubMed Schwarz C, Regele H, Steininger R, Hansmann C, Mayer G, Oberbauer R: The contribution of adhesion molecule expression in donor kidney biopsies to early allograft dysfunction. Transplantation. 2001, 71: 1666-1670. 10.1097/00007890-200106150-00028.CrossRefPubMed
26.
go back to reference Ogliari AC, Caldara R, Socci C, Sordi V, Cagni N, Moretti MP, Dell’acqua A, Mercalli A, Scavini M, Secchi A: High levels of donor CCL2/MCP-1 predict graft-related complications and poor graft survival after kidney-pancreas transplantation. Am J Transplant. 2008, 8: 1303-1311. 10.1111/j.1600-6143.2008.02240.x.CrossRefPubMed Ogliari AC, Caldara R, Socci C, Sordi V, Cagni N, Moretti MP, Dell’acqua A, Mercalli A, Scavini M, Secchi A: High levels of donor CCL2/MCP-1 predict graft-related complications and poor graft survival after kidney-pancreas transplantation. Am J Transplant. 2008, 8: 1303-1311. 10.1111/j.1600-6143.2008.02240.x.CrossRefPubMed
27.
go back to reference Reynaud-Gaubert M, Marin V, Thirion X, Farnarier C, Thomas P, Badier M, Bongrand P, Giudicelli R, Fuentes P: Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant. 2002, 21: 721-730. 10.1016/S1053-2498(02)00392-3.CrossRefPubMed Reynaud-Gaubert M, Marin V, Thirion X, Farnarier C, Thomas P, Badier M, Bongrand P, Giudicelli R, Fuentes P: Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant. 2002, 21: 721-730. 10.1016/S1053-2498(02)00392-3.CrossRefPubMed
28.
go back to reference Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI: Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010, 14: 1419-1431.PubMedCentralCrossRefPubMed Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI: Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010, 14: 1419-1431.PubMedCentralCrossRefPubMed
29.
go back to reference Dong XQ, Hu YY, Yu WH, Zhang ZY: High concentrations of resistin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. J Crit Care. 2010, 25: 243-247. 10.1016/j.jcrc.2009.09.008.CrossRefPubMed Dong XQ, Hu YY, Yu WH, Zhang ZY: High concentrations of resistin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. J Crit Care. 2010, 25: 243-247. 10.1016/j.jcrc.2009.09.008.CrossRefPubMed
30.
go back to reference Dong XQ, Yang SB, Zhu FL, Lv QW, Zhang GH, Huang HB: Resistin is associated with mortality in patients with traumatic brain injury. Crit Care. 2010, 14: R190-10.1186/cc9307.PubMedCentralCrossRefPubMed Dong XQ, Yang SB, Zhu FL, Lv QW, Zhang GH, Huang HB: Resistin is associated with mortality in patients with traumatic brain injury. Crit Care. 2010, 14: R190-10.1186/cc9307.PubMedCentralCrossRefPubMed
31.
go back to reference Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, Mountokalakis TD: Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta. 2007, 378: 78-85. 10.1016/j.cca.2006.10.023.CrossRefPubMed Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, Mountokalakis TD: Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke. Clin Chim Acta. 2007, 378: 78-85. 10.1016/j.cca.2006.10.023.CrossRefPubMed
32.
go back to reference Axelsson J, Bergsten A, Qureshi AR, Heimburger O, Barany P, Lonnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006, 69: 596-604. 10.1038/sj.ki.5000089.CrossRefPubMed Axelsson J, Bergsten A, Qureshi AR, Heimburger O, Barany P, Lonnqvist F, Lindholm B, Nordfors L, Alvestrand A, Stenvinkel P: Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int. 2006, 69: 596-604. 10.1038/sj.ki.5000089.CrossRefPubMed
33.
go back to reference Almehed K, d’Elia HF, Bokarewa M, Carlsten H: Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther. 2008, 10: R15-10.1186/ar2366.PubMedCentralCrossRefPubMed Almehed K, d’Elia HF, Bokarewa M, Carlsten H: Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther. 2008, 10: R15-10.1186/ar2366.PubMedCentralCrossRefPubMed
34.
go back to reference Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D: Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis. 2003, 42: 62-66. 10.1016/S0272-6386(03)00409-8.CrossRefPubMed Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D: Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis. 2003, 42: 62-66. 10.1016/S0272-6386(03)00409-8.CrossRefPubMed
35.
go back to reference Murugan R, Venkataraman R, Wahed AS, Elder M, Hergenroeder G, Carter M, Madden NJ, Powner D, Kellum JA: Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med. 2008, 36: 1810-1816. 10.1097/CCM.0b013e318174d89f.CrossRefPubMed Murugan R, Venkataraman R, Wahed AS, Elder M, Hergenroeder G, Carter M, Madden NJ, Powner D, Kellum JA: Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med. 2008, 36: 1810-1816. 10.1097/CCM.0b013e318174d89f.CrossRefPubMed
36.
go back to reference Damman J, Daha MR, van Son WJ, Leuvenink HG, Ploeg RJ, Seelen MA: Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am J Transplant. 2011, 11: 660-669. 10.1111/j.1600-6143.2011.03475.x.CrossRefPubMed Damman J, Daha MR, van Son WJ, Leuvenink HG, Ploeg RJ, Seelen MA: Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am J Transplant. 2011, 11: 660-669. 10.1111/j.1600-6143.2011.03475.x.CrossRefPubMed
37.
go back to reference Alakulppi NS, Kyllonen LE, Jantti VT, Matinlauri IH, Partanen J, Salmela KT, Laine JT: Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation. 2004, 78: 1422-1428. 10.1097/01.TP.0000140884.71571.BC.CrossRefPubMed Alakulppi NS, Kyllonen LE, Jantti VT, Matinlauri IH, Partanen J, Salmela KT, Laine JT: Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation. 2004, 78: 1422-1428. 10.1097/01.TP.0000140884.71571.BC.CrossRefPubMed
38.
go back to reference Hollmen ME, Kyllonen LE, Inkinen KA, Lalla ML, Merenmies J, Salmela KT: Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Crit Care. 2011, 15: R121-10.1186/cc10220.PubMedCentralCrossRefPubMed Hollmen ME, Kyllonen LE, Inkinen KA, Lalla ML, Merenmies J, Salmela KT: Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study. Crit Care. 2011, 15: R121-10.1186/cc10220.PubMedCentralCrossRefPubMed
39.
go back to reference Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ: Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant. 2002, 16: 425-429. 10.1034/j.1399-0012.2002.02055.x.CrossRefPubMed Humar A, Ramcharan T, Kandaswamy R, Gillingham K, Payne WD, Matas AJ: Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant. 2002, 16: 425-429. 10.1034/j.1399-0012.2002.02055.x.CrossRefPubMed
40.
go back to reference Yarlagadda SG, Coca SG, Garg AX, Doshi M, Poggio E, Marcus RJ, Parikh CR: Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant. 2008, 23: 2995-3003. 10.1093/ndt/gfn158.PubMedCentralCrossRefPubMed Yarlagadda SG, Coca SG, Garg AX, Doshi M, Poggio E, Marcus RJ, Parikh CR: Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant. 2008, 23: 2995-3003. 10.1093/ndt/gfn158.PubMedCentralCrossRefPubMed
41.
go back to reference Otukesh H, Hosein R, Fereshtehnejad SM, Riahifard A, Basiri A, Simforoosh N, Chalian M, Jazayeri S, Chalian H, Safarzadeh AE: Short-term and long-term effects of slow graft function on graft survival in pediatric live donor renal transplantation. Pediatr Transplant. 2010, 14: 196-202. 10.1111/j.1399-3046.2009.01191.x.CrossRefPubMed Otukesh H, Hosein R, Fereshtehnejad SM, Riahifard A, Basiri A, Simforoosh N, Chalian M, Jazayeri S, Chalian H, Safarzadeh AE: Short-term and long-term effects of slow graft function on graft survival in pediatric live donor renal transplantation. Pediatr Transplant. 2010, 14: 196-202. 10.1111/j.1399-3046.2009.01191.x.CrossRefPubMed
42.
go back to reference Port FK, Bragg-Gresham JL, Metzger RA, Dykstra DM, Gillespie BW, Young EW, Delmonico FL, Wynn JJ, Merion RM, Wolfe RA, Held PJ: Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation. 2002, 74: 1281-1286. 10.1097/00007890-200211150-00014.CrossRefPubMed Port FK, Bragg-Gresham JL, Metzger RA, Dykstra DM, Gillespie BW, Young EW, Delmonico FL, Wynn JJ, Merion RM, Wolfe RA, Held PJ: Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation. 2002, 74: 1281-1286. 10.1097/00007890-200211150-00014.CrossRefPubMed
Metadata
Title
Increased resistin in brain dead organ donors is associated with delayed graft function after kidney transplantation
Authors
Simona Oltean
Rille Pullerits
Anne Flodén
Michael Olausson
Mihai Oltean
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2013
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-11-233

Other articles of this Issue 1/2013

Journal of Translational Medicine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.